Advertisement

Synbiotics Corp., a manufacturer of diagnostic and...

Share via

Synbiotics Corp., a manufacturer of diagnostic and therapeutic products based on monoclonal antibody technology, reported a third quarter loss of $41,000 on revenue of $1.6 million, compared with a loss of $56,000 on revenue of $1.4 million over the same period last year.

Advertisement